The global scaffold technology market size is expected to reach USD 2.22 billion by 2028 according to this new study. The report “Global Scaffold Technology Market Share, Size, Trends, Industry Analysis Report, By Type (Hydrogels {Wound Healing, 3D Bioprinting, Immunomodulation}, Polymeric Scaffolds, Micropatterned Surface Microplates, Nanofiber Based Scaffolds); By Application; By Disease Type; By End-Use; By Regions; Segment Forecast, 2021-2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
The recent advancements in micro-molding, photo-lithography, and stereo-lithography also driving scaffolding technology. For instance, the innovations in injectable and microporous hydrogels also enabled organ on a chip technology to enhance in-vivo healing. Moreover, ongoing advancements in micro-fabrication technology are also projected to boost the market growth.
In 2020, the hydrogels market segment of scaffold technology industry had the largest revenue share. This high share is attributed to the excellent properties of hydrogels, such as controlled drug delivery, and ease of loading drugs. In current times, hydrogels have gained momentum and are regarded as a leading candidate in 3D cell cultures and tissue engineering.
The nanofiber scaffolds segment is projected to show the fastest growth rate over the assessment period. Nanoscale fibrous structures with inter-connecting pores facilitate the formation of artificial tissues during the process of tissue engineering. Artificial tissues resemble natural ones, by providing an extracellular matrix of the living tissues.
Market participants such as Merck KGaA, Molecular Matrix, Pelobiotech, Corning Incorporated, Avacta Life Sciences Limited, Vericel Corporation, Becton, Dickinson and Company, 3D Biotek LLC, Thermo Fisher Scientific, Xanofi, REPROCELL Inc., Matricel GmbH, Akron Biotech, Nanofiber Solutions, 4titude, 3D BioMatrix, NuVasive, Inc., Allergan, and Medtronic. are some of the key players operating in the global market for scaffold technology.
Players in the marketplace are collaborating with small players to stay competitive in the market for scaffold technology. For instance, in October 2019, Avacta Life Sciences collaboration agreement with ADC Therapeutics to develop Affimer drug conjugates, to use in biological scaffolds.
The recent advancements in micro-molding, photo-lithography, and stereo-lithography also driving scaffolding technology. For instance, the innovations in injectable and microporous hydrogels also enabled organ on a chip technology to enhance in-vivo healing. Moreover, ongoing advancements in micro-fabrication technology are also projected to boost the market growth.
In 2020, the hydrogels market segment of scaffold technology industry had the largest revenue share. This high share is attributed to the excellent properties of hydrogels, such as controlled drug delivery, and ease of loading drugs. In current times, hydrogels have gained momentum and are regarded as a leading candidate in 3D cell cultures and tissue engineering.
The nanofiber scaffolds segment is projected to show the fastest growth rate over the assessment period. Nanoscale fibrous structures with inter-connecting pores facilitate the formation of artificial tissues during the process of tissue engineering. Artificial tissues resemble natural ones, by providing an extracellular matrix of the living tissues.
Market participants such as Merck KGaA, Molecular Matrix, Pelobiotech, Corning Incorporated, Avacta Life Sciences Limited, Vericel Corporation, Becton, Dickinson and Company, 3D Biotek LLC, Thermo Fisher Scientific, Xanofi, REPROCELL Inc., Matricel GmbH, Akron Biotech, Nanofiber Solutions, 4titude, 3D BioMatrix, NuVasive, Inc., Allergan, and Medtronic. are some of the key players operating in the global market for scaffold technology.
Players in the marketplace are collaborating with small players to stay competitive in the market for scaffold technology. For instance, in October 2019, Avacta Life Sciences collaboration agreement with ADC Therapeutics to develop Affimer drug conjugates, to use in biological scaffolds.
The publisher has segmented the scaffold technology market report on the basis of type, application, disease type, end-use, and region:
Scaffold Technology, Type Outlook (Revenue-USD Million, 2016-2028)
- Hydrogels
- Wound Healing
- 3D Bioprinting
- Immunomodulation
- Polymeric Scaffolds
- Micropatterned Surface Microplates
- Nanofiber Based Scaffolds
Scaffold Technology, Application Outlook (Revenue-USD Million, 2016-2028)
- Stem Cell Therapy, Regenerative Medicine, & Tissue Engineering
- Drug Discovery
- Others
Scaffold Technology, Disease Type Outlook (Revenue-USD Million, 2016-2028)
- Orthopedics, Musculoskeletal, & Spine
- Cancer
- Skin & Integumentary
- Dental
- Cardiology & Vascular
- Neurology
- Urology
- GI & Gynecology
- Others
Scaffold Technology, End Use Outlook (Revenue-USD Million, 2016-2028)
- Biotechnology and Pharmaceutical Industries
- Research Laboratories and Institutes
- Hospitals and Diagnostic Centers
- Others
Scaffold Technology, Regional Outlook (Revenue-USD Million, 2016-2028)
- North America
- U.S.
- Canada
- Europe
- France
- Germany
- UK
- Italy
- Spain
- Netherlands
- Austria
- Asia Pacific
- China
- India
- Japan
- Malaysia
- South Korea
- Indonesia
- Central & South America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Frequently Asked Questions about the Scaffold Technology Market
What is the estimated value of the Scaffold Technology Market?
What is the growth rate of the Scaffold Technology Market?
What is the forecasted size of the Scaffold Technology Market?
Who are the key companies in the Scaffold Technology Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 110 |
| Published | February 2021 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 1.11 Billion |
| Forecasted Market Value ( USD | $ 2.22 Billion |
| Compound Annual Growth Rate | 10.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
Table of Contents
1. Introduction
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
1.1. Report Description
1.1.1. Objectives of the Study
1.1.2. Market Scope
1.1.3. Assumptions
1.2. Stakeholders
2. Executive Summary
3. Research Methodology
4. Scaffold Technology Market Insights
5. Scaffold Technology Market Assessment by Type
6. Global Scaffold Technology Market, by Application
7. Global Scaffold Technology Market, by Disease Type
8. Scaffold Technology Market Assessment by End Use
9. Scaffold Technology Market Assessment by Geography
10. Competitive Landscape
11. Company Profiles
List of Tables
Companies Mentioned
- Merck KGaA
- Molecular Matrix
- Pelobiotech
- Corning Incorporated
- Avacta Life Sciences Limited
- Vericel Corporation
- Becton
- Dickinson
- Company
- 3D Biotek LLC
- Thermo Fisher Scientific
- Xanofi
- REPROCELL Inc.
- Matricel GmbH
- Akron Biotech
- Nanofiber Solutions
- 4titude
- 3D BioMatrix
- NuVasive Inc.
- Allergan
- Medtronic
